In a Phase II trial in ulcerative colitis, BPC-157 (also referred to by a code like PL 14736) reportedly helped induce remission of the disease and was noted to be well-tolerated with no side effects
The association with MDD appeared stronger in females than in males, although the formal test for a sex difference was not statistically significant
Weight loss is the marquee outcome, but comorbidity studies (sleep apnea, osteoarthritis pain, cardiometabolic markers) increasingly define how payers and regulators judge value. Frequently Asked Questions What is berobenatide
Lastly, if the medication has been exposed to extreme temperatures, either too hot or too cold, it's best to consult your healthcare provider before using it
March 2026: roughly 30 more warning letters go out
Nutrition, epigenetics, and major depressive disorder: understanding the connection